{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:30:12Z","timestamp":1765333812764,"version":"3.46.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108691","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:46:49Z","timestamp":1758599209000},"page":"108691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Methyl 2-(7-hydroxy-3-methyloctyl)-1,3-dimethyl-4-oxocyclohex-2-enecarboxylate as a natural and potent antitubercular lead: An in silico study integrating molecular docking, molecular dynamics, FMO, and DFT analyses"],"prefix":"10.1016","volume":"120","author":[{"given":"Fathima","family":"Asra","sequence":"first","affiliation":[]},{"given":"Kannan","family":"Vadivel","sequence":"additional","affiliation":[]},{"given":"Srikanth","family":"Jeyabalan","sequence":"additional","affiliation":[]},{"given":"Srilekha","family":"Chintala","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-6909","authenticated-orcid":false,"given":"Naresh","family":"Dumala","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108691_bib1","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1080\/10406638.2022.2083195","article-title":"Molecular structure, spectroscopic elucidation (FT-IR, FT-Raman, UV-Visible and NMR) with NBO, ELF, LOL, RDG, fukui, drug likeness and molecular docking analysis on dimethomorph","volume":"43","author":"Abisha","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib3","first-page":"165","article-title":"Secondary metabolites: secondary metabolic products consisting of c and H; C, H, and O; N, S, and p elements; and O\/N heterocycles","author":"Alamgir","year":"2018","journal-title":"Ther. Use Med. Plants their Extr. Vol. 2 Phytochem. Bioact. Compd."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12889-024-17747-z","article-title":"Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS-CoV-2 infectivity","volume":"24","author":"Alkafaas","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13721-024-00451-8","article-title":"Computational screening identifies depsidones as promising aurora a kinase inhibitors: extra precision docking and molecular dynamics studies","volume":"13","author":"Almogaddam","year":"2024","journal-title":"Netw. Model. Anal. Health Inform. Bioinforma."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108691_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/acs.chemrestox.3c00352","article-title":"Advancing drug safety in drug development: bridging computational predictions for enhanced toxicity prediction","volume":"37","author":"Amorim","year":"2024","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.sajb.2025.04.021","article-title":"Plant-based multi-target directed antitubercular ligand identification from Ipomea sepiaria with application of bioinformatics methodology","volume":"181","author":"Asra","year":"2025","journal-title":"S. Afr. J. Bot."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108691_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.31643\/2023\/6445.13","article-title":"SwissADME and pkCSM webservers predictors: an integrated online platform for accurate and comprehensive predictions for in silico ADME\/T properties of artemisinin and its derivatives","volume":"325","author":"Azzam","year":"2023","journal-title":"Kompleks. Ispolzovanie Miner. Syra= Complex Use Miner. Resour."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-18937-1_1","article-title":"Tuberculosis in ancient Egypt","author":"Bedeir","year":"2004","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108691_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10837450902891295","article-title":"Drug metabolism and pharmacokinetics","volume":"41","author":"Benedetti","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib11","article-title":"Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination. Goodman and Gilman\u2019s the pharmacological basis of therapeutics","volume":"3","author":"Benet","year":"1996"},{"issue":"14","key":"10.1016\/j.compbiolchem.2025.108691_bib12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1080\/08927022.2021.1957884","article-title":"An in silico molecular dynamics simulation study on the inhibitors of SARS-CoV-2 proteases (3CLpro and PLpro) to combat COVID-19","volume":"47","author":"Bera","year":"2021","journal-title":"Mol. Simul."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-5-27","article-title":"Role of cytochrome P450 in drug interactions","volume":"5","author":"Bibi","year":"2008","journal-title":"Nutr. Metab."},{"issue":"11","key":"10.1016\/j.compbiolchem.2025.108691_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202300115","article-title":"Absorption matters: a closer look at popular oral bioavailability rules for drug approvals","volume":"42","author":"Caminero Gomes Soares","year":"2023","journal-title":"Mol. Inform."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ddc3010011","article-title":"Plant-Derived natural products: a source for drug discovery and development","volume":"3","author":"Chaachouay","year":"2024","journal-title":"Drugs Drug Candidates"},{"issue":"18","key":"10.1016\/j.compbiolchem.2025.108691_bib16","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1080\/07391102.2023.2251070","article-title":"Broadening the scope of WEE1 inhibitors: identifying novel drug candidates via computational approaches and drug repurposing","volume":"42","author":"Chandrasekaran","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108691_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/molecules23040911","article-title":"Evaluating molecular properties involved in transport of small molecules in stratum corneum: a quantitative structure-activity relationship for skin permeability","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/atm-20-4289","article-title":"The role of CYP3A4 in the biotransformation of bile acids and therapeutic implications for cholestasis","volume":"2","author":"Chen","year":"2014","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108691_bib19","article-title":"Computational approach to evaluate the potential of some phytocompounds of flacourtia jangomas against UDP-GlcF enzyme of mycobacterium tuberculosis (Mtb)","volume":"45","author":"Choudhury","year":"2024","journal-title":"J. Adv. Zool."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108691_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00045391-200311000-00013","article-title":"QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs","volume":"10","author":"Cubeddu","year":"2003","journal-title":"Am. J. Ther."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108691_bib21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s12033-023-00831-x","article-title":"Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-bond, SASA and MMGBSA","volume":"66","author":"da Fonseca","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108691_bib22","article-title":"An overview of molecular docking","volume":"14","author":"Dighe","year":"2024","journal-title":"Asian J. Pharm. Res."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101482","article-title":"Homology modeling, binding site identification, molecular docking and molecular dynamics simulation study of emerging and promising drug target of wnt signaling\u2013Human porcupine enzyme","volume":"7","author":"Goswami","year":"2024","journal-title":"Results Chem."},{"year":"2012","series-title":"Prediction of drug distribution in rat and human","author":"Graham","key":"10.1016\/j.compbiolchem.2025.108691_bib24"},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108691_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acs.jcim.8b00095","article-title":"Temperature-shuffled structural dissimilarity sampling based on a root-mean-square deviation","volume":"58","author":"Harada","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/1735-5362.363597","article-title":"Preparing a database of corrected protein structures important in cell signaling pathways","volume":"18","author":"Hatami","year":"2023","journal-title":"Res. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108691_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/minf.201100135","article-title":"Free energy calculations by the molecular mechanics poisson\u2212 boltzmann surface area method","volume":"31","author":"Homeyer","year":"2012","journal-title":"Mol. Inform."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108691_bib28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108691_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ddr.21918","article-title":"Approaches to minimize the effects of P-glycoprotein in drug transport: a review","volume":"83","author":"Husain","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib30","series-title":"Recent Advances in Industrial Biochemistry","first-page":"251","article-title":"Current trends in the biosynthesis of vitamins","author":"Irfan","year":"2024"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108691_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/toxics9120340","article-title":"Determination of median lethal concentration (LC50) for endosulfan, heptachlor and dieldrin pesticides to African catfish, clarias gariepinus and their impact on its behavioral patterns and histopathological responses","volume":"9","author":"Islam","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.compbiolchem.2025.108691_bib32","series-title":"Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development","first-page":"393","article-title":"Molecular dynamics in predicting the stability of drug-receptor interactions","author":"Jayaram","year":"2023"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.103.053298","article-title":"Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)","volume":"308","author":"Jonker","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mrgentox.2014.10.005","article-title":"Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. reports of individual databases presented at an EURL ECVAM workshop","volume":"775","author":"Kirkland","year":"2014","journal-title":"Mutat. Res. \/Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108081","article-title":"Molecular dynamics simulations reveal the plausible agonism\/antagonism mechanism by steroids on androgen receptor mutations","volume":"111","author":"Kocak","year":"2022","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.24959\/ophcj.25.321860","article-title":"Balancing physicochemical properties between the molecules of mercy (Non-Addictive Drugs) and the molecules of mysticism (Often Addictive Drugs)","volume":"23","author":"Kraus","year":"2025","journal-title":"J. Org. Pharm. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108691_bib37","doi-asserted-by":"crossref","first-page":"bbae321","DOI":"10.1093\/bib\/bbae321","article-title":"DrugMetric: quantitative drug-likeness scoring based on chemical space distance","volume":"25","author":"Li","year":"2024","journal-title":"Brief. Bioinforma."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108691_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today. Technol."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108691_bib39","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1021\/acs.jcim.7b00412","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: a cross-docking study","volume":"57","author":"Liu","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108691_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17460441.2019.1581170","article-title":"DataWarrior: an evaluation of the open-source drug discovery tool","volume":"14","author":"L\u00f3pez-L\u00f3pez","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108691_bib41","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/microorganisms11092277","article-title":"Tackling drug-resistant tuberculosis: new challenges from the old pathogen mycobacterium tuberculosis","volume":"11","author":"Mancuso","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.compbiolchem.2025.108691_bib42","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S0102-695X2012005000025","article-title":"Review of the genus ipomoea: traditional uses, chemistry, and biological activities","volume":"22","author":"Meira","year":"2012","journal-title":"Rev. Bras. De. Farmacogn."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib43","unstructured":"Mursal M., Ahmad M., Hussain S., Khan M.F. Navigating the computational seas: a comprehensive overview of molecular docking software in drug discovery."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108691_bib44","first-page":"56","article-title":"Human immunodeficiency virus and tuberculosis infection: a review of prevalence of associated factors","volume":"10","author":"Obeagu","year":"2023","journal-title":"Int. J. Adv. Multidiscip. Res."},{"issue":"14","key":"10.1016\/j.compbiolchem.2025.108691_bib45","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4155\/fmc-2017-0124","article-title":"The potential role of in silico approaches to identify novel bioactive molecules from natural resources","volume":"9","author":"Ol\u011fa\u00e7","year":"2017","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108691_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","article-title":"Software for molecular docking: a review","volume":"9","author":"Pagadala","year":"2017","journal-title":"Biophys. Rev."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108691_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejps.2010.05.014","article-title":"Prediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks","volume":"41","author":"Paix\u00e3o","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.compbiolchem.2025.108691_bib48","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1080\/07391102.2023.2275179","article-title":"Molecular docking and dynamic simulation studies of isoflavones inhibiting Lox-2 activity for reducing beany flavor in soybean seeds","volume":"42","author":"Patel","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108691_bib49","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108691_bib50","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4939-7756-7_14","article-title":"Prediction and optimization of pharmacokinetic and toxicity properties of the ligand","author":"Pires","year":"2018","journal-title":"Comput. Drug Discov. Des."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-3609-0_9","article-title":"In silico models for repeated-dose toxicity (RDT): prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs","author":"Pizzo","year":"2016","journal-title":"silico Methods Predict. Drug Toxic."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib53","article-title":"Synthesis, spectroscopic investigations, topological non-covalent interactions, chemical reactivity, molecular docking and molecular dynamic simulation on piperazine succinate-A potential antimicrobial compound","volume":"1292","author":"Reeda","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108691_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17460441.2023.2275617","article-title":"Evaluating physiochemical properties of FDA-approved orally administered drugs","volume":"19","author":"Reese","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108691_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17460441.2023.2275617","article-title":"Evaluating physiochemical properties of FDA-approved orally administered drugs","volume":"19","author":"Reese","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpc.2021.107931","article-title":"GROMACS implementation of free energy calculations with non-pairwise variationally derived intermediates","volume":"264","author":"Reinhardt","year":"2021","journal-title":"Comput. Phys. Commun."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108691_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00894-023-05586-5","article-title":"Molecular modeling study of natural products as potential bioactive compounds against SARS-CoV-2","volume":"29","author":"Ribeiro","year":"2023","journal-title":"J. Mol. Model."},{"issue":"36","key":"10.1016\/j.compbiolchem.2025.108691_bib58","doi-asserted-by":"crossref","first-page":"32244","DOI":"10.1021\/acsomega.3c02563","article-title":"Overcoming mycobacterium tuberculosis drug resistance: novel medications and repositioning strategies","volume":"8","author":"Sachan","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiolchem.2025.108691_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addr.2012.09.027","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"64","author":"Schinkel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108691_bib60","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4155\/fmc.12.68","article-title":"Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges","volume":"4","author":"Sharma","year":"2012","journal-title":"Future Med. Chem."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108691_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104856","article-title":"Production of higher toxic intermediates of organic pollutants during chemical oxidation processes: a review","volume":"16","author":"Shi","year":"2023","journal-title":"Arab. J. Chem."},{"year":"2022","series-title":"Density functional theory: a practical introduction","author":"Sholl","key":"10.1016\/j.compbiolchem.2025.108691_bib62"},{"key":"10.1016\/j.compbiolchem.2025.108691_bib63","series-title":"2-Deoxy-D-Glucose: Chemistry and Biology","first-page":"242","article-title":"Lipinski s rule of five","author":"Singh","year":"2024"},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108691_bib64","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1021\/acs.jchemed.0c00959","article-title":"Computational chemistry activities with avogadro and ORCA","volume":"98","author":"Snyder","year":"2021","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib65","doi-asserted-by":"crossref","DOI":"10.23736\/S0392-0488.20.06698-5","article-title":"Skin tests in the diagnosis of adverse drug reactions: a systematic review","author":"Stingeni","year":"2020","journal-title":"G. Ital. di Dermatol. e Venereol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108691_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/mabi.201000206","article-title":"Affinity-based drug delivery","volume":"11","author":"Wang","year":"2011","journal-title":"Macromol. Biosci."},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108691_bib67","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1046\/j.1365-2672.1999.00771.x","article-title":"Comparative toxicity of four microcystins of different hydrophobicities to the protozoan, tetrahymena pyriformis","volume":"86","author":"Ward","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib68","unstructured":"WHO Global Tuberculosis reports, 21 April 2023."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108691_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2004.10.021","article-title":"Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics","volume":"204","author":"Wright","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2025.108691_bib70","unstructured":"Zindoga A. Structure-based hit-to-lead design, optimization, and synthesis of tetrahydro-1, 3, 5-triazine-2-amine derivatives as potential inhibitors of Mycobacterium tuberculosis Dihydrofolate Reductase (MtbDHFR) (Doctoral dissertation, Chinhoyi University of Technology)."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:27:10Z","timestamp":1765333630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125003524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":70,"alternative-id":["S1476927125003524"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108691","relation":{},"ISSN":["1476-9271"],"issn-type":[{"type":"print","value":"1476-9271"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methyl 2-(7-hydroxy-3-methyloctyl)-1,3-dimethyl-4-oxocyclohex-2-enecarboxylate as a natural and potent antitubercular lead: An in silico study integrating molecular docking, molecular dynamics, FMO, and DFT analyses","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108691"}}